Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016092552> ?p ?o ?g. }
- W2016092552 endingPage "385" @default.
- W2016092552 startingPage "379" @default.
- W2016092552 abstract "The Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation has conducted a long-term bioassay on aspartame (APM), a widely used artificial sweetener. APM was administered with feed to 8-week-old Sprague-Dawley rats (100-150/sex/group), at concentrations of 100,000, 50,000, 10,000, 2,000, 400, 80, or 0 ppm. The treatment lasted until natural death, at which time all deceased animals underwent complete necropsy. Histopathologic evaluation of all pathologic lesions and of all organs and tissues collected was routinely performed on each animal of all experimental groups. The results of the study show for the first time that APM, in our experimental conditions, causes a) an increased incidence of malignant-tumor-bearing animals with a positive significant trend in males (p < or = 0.05) and in females (p < or = 0.01), in particular those females treated at 50,000 ppm (p < or = 0.01); b) an increase in lymphomas and leukemias with a positive significant trend in both males (p < or = 0.05) and females (p < or = 0.01), in particular in females treated at doses of 100,000 (p < or = 0.01), 50,000 (p < or = 0.01), 10,000 (p < or = 0.05), 2,000 (p < or = 0.05), or 400 ppm (p < or = 0.01); c) a statistically significant increased incidence, with a positive significant trend (p < or = 0.01), of transitional cell carcinomas of the renal pelvis and ureter and their precursors (dysplasias) in females treated at 100,000 (p < or = 0.01), 50,000 (p < or = 0.01), 10,000 (p < or = 0.01), 2,000 (p < or = 0.05), or 400 ppm (p < or = 0.05); and d) an increased incidence of malignant schwannomas of peripheral nerves with a positive trend (p < or = 0.05) in males. The results of this mega-experiment indicate that APM is a multipotential carcinogenic agent, even at a daily dose of 20 mg/kg body weight, much less than the current acceptable daily intake. On the basis of these results, a reevaluation of the present guidelines on the use and consumption of APM is urgent and cannot be delayed." @default.
- W2016092552 created "2016-06-24" @default.
- W2016092552 creator A5017344340 @default.
- W2016092552 creator A5058576259 @default.
- W2016092552 creator A5074615009 @default.
- W2016092552 creator A5081307331 @default.
- W2016092552 creator A5083227205 @default.
- W2016092552 creator A5090194713 @default.
- W2016092552 date "2006-03-01" @default.
- W2016092552 modified "2023-10-12" @default.
- W2016092552 title "First Experimental Demonstration of the Multipotential Carcinogenic Effects of Aspartame Administered in the Feed to Sprague-Dawley Rats" @default.
- W2016092552 cites W1505892586 @default.
- W2016092552 cites W1559503651 @default.
- W2016092552 cites W1974270379 @default.
- W2016092552 cites W1977054641 @default.
- W2016092552 cites W1981307622 @default.
- W2016092552 cites W1986443759 @default.
- W2016092552 cites W2007721053 @default.
- W2016092552 cites W2014720929 @default.
- W2016092552 cites W2028348553 @default.
- W2016092552 cites W2037006831 @default.
- W2016092552 cites W2042430444 @default.
- W2016092552 cites W2079685994 @default.
- W2016092552 cites W2080907318 @default.
- W2016092552 cites W2101983957 @default.
- W2016092552 cites W2113484264 @default.
- W2016092552 cites W2115180122 @default.
- W2016092552 cites W2133943786 @default.
- W2016092552 cites W2146301263 @default.
- W2016092552 cites W2158631163 @default.
- W2016092552 cites W2161960007 @default.
- W2016092552 cites W2312872381 @default.
- W2016092552 cites W2325373098 @default.
- W2016092552 cites W3093530844 @default.
- W2016092552 cites W3093915039 @default.
- W2016092552 cites W3094042536 @default.
- W2016092552 cites W3094104866 @default.
- W2016092552 cites W4246763603 @default.
- W2016092552 cites W4299350407 @default.
- W2016092552 cites W4301905417 @default.
- W2016092552 doi "https://doi.org/10.1289/ehp.8711" @default.
- W2016092552 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1392232" @default.
- W2016092552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16507461" @default.
- W2016092552 hasPublicationYear "2006" @default.
- W2016092552 type Work @default.
- W2016092552 sameAs 2016092552 @default.
- W2016092552 citedByCount "204" @default.
- W2016092552 countsByYear W20160925522012 @default.
- W2016092552 countsByYear W20160925522013 @default.
- W2016092552 countsByYear W20160925522014 @default.
- W2016092552 countsByYear W20160925522015 @default.
- W2016092552 countsByYear W20160925522016 @default.
- W2016092552 countsByYear W20160925522017 @default.
- W2016092552 countsByYear W20160925522018 @default.
- W2016092552 countsByYear W20160925522019 @default.
- W2016092552 countsByYear W20160925522020 @default.
- W2016092552 countsByYear W20160925522021 @default.
- W2016092552 countsByYear W20160925522022 @default.
- W2016092552 countsByYear W20160925522023 @default.
- W2016092552 crossrefType "journal-article" @default.
- W2016092552 hasAuthorship W2016092552A5017344340 @default.
- W2016092552 hasAuthorship W2016092552A5058576259 @default.
- W2016092552 hasAuthorship W2016092552A5074615009 @default.
- W2016092552 hasAuthorship W2016092552A5081307331 @default.
- W2016092552 hasAuthorship W2016092552A5083227205 @default.
- W2016092552 hasAuthorship W2016092552A5090194713 @default.
- W2016092552 hasBestOaLocation W20160925521 @default.
- W2016092552 hasConcept C104488531 @default.
- W2016092552 hasConcept C114246631 @default.
- W2016092552 hasConcept C120665830 @default.
- W2016092552 hasConcept C121332964 @default.
- W2016092552 hasConcept C121608353 @default.
- W2016092552 hasConcept C126322002 @default.
- W2016092552 hasConcept C2778278337 @default.
- W2016092552 hasConcept C42407357 @default.
- W2016092552 hasConcept C54355233 @default.
- W2016092552 hasConcept C55493867 @default.
- W2016092552 hasConcept C61511704 @default.
- W2016092552 hasConcept C71924100 @default.
- W2016092552 hasConcept C86803240 @default.
- W2016092552 hasConcept C90924648 @default.
- W2016092552 hasConceptScore W2016092552C104488531 @default.
- W2016092552 hasConceptScore W2016092552C114246631 @default.
- W2016092552 hasConceptScore W2016092552C120665830 @default.
- W2016092552 hasConceptScore W2016092552C121332964 @default.
- W2016092552 hasConceptScore W2016092552C121608353 @default.
- W2016092552 hasConceptScore W2016092552C126322002 @default.
- W2016092552 hasConceptScore W2016092552C2778278337 @default.
- W2016092552 hasConceptScore W2016092552C42407357 @default.
- W2016092552 hasConceptScore W2016092552C54355233 @default.
- W2016092552 hasConceptScore W2016092552C55493867 @default.
- W2016092552 hasConceptScore W2016092552C61511704 @default.
- W2016092552 hasConceptScore W2016092552C71924100 @default.
- W2016092552 hasConceptScore W2016092552C86803240 @default.
- W2016092552 hasConceptScore W2016092552C90924648 @default.
- W2016092552 hasIssue "3" @default.
- W2016092552 hasLocation W20160925521 @default.
- W2016092552 hasLocation W20160925522 @default.